| # | Drug | Count |
|---|---|---|
| 0 | PANITUMUMAB | 5 |
| 1 | VEMURAFENIB | 4 |
| 2 | GABAPENTIN | 2 |
| 3 | CARBOPLATIN | 1 |
| 4 | LEUPROLIDE ACETATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VEMURAFENIB | 4 | 0.0003 |
| 1 | PANITUMUMAB | 5 | 0.0003 |
| 2 | LEUPROLIDE ACETATE | 1 | 0.0000 |
| 3 | CARBOPLATIN | 1 | 0.0000 |
| 4 | GABAPENTIN | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 |
| 1 | Kinase Inhibitor [EPC] | 4 |
| 2 | Platinum-based Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 1 | Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |